Details
Happening today! 🚨
Join HFSA's Cardio Town Hall: Expert Perspectives on Contemporary ATTR-CM Clinical Research for a live discussion on the latest clinical research shaping the future of transthyretin amyloidosis with cardiomyopathy (ATTR-CM).
Hear leading experts review emerging clinical trials, liver-targeted therapies designed to reduce transthyretin production, and what these advances may mean for clinical practice.